Antithrombotic therapy
David, J.L.
Revue Medicale de Liege 35(9): 363-372
1980
ISSN/ISBN: 0370-629X PMID: 7466058 Document Number: 155792
Document emailed within 1 workday
Related Documents
DiMinno, G.; Silver, M.J. 1983: Mouse antithrombotic assay: a simple method for the evaluation of antithrombotic agents in vivo. Potentiation of antithrombotic activity by ethyl alcohol Journal of Pharmacology and Experimental Therapeutics 225(1): 57-60Bŭcharova, V. 1990: The current aspects of antithrombotic therapy Vutreshni Bolesti 29(3): 14-20
Koller, F. 1982: Antithrombotic therapy of myocardial infarction Schweizerische Rundschau für Medizin Praxis 71(38): 1449-1453
Shechter, M. 2000: The role of magnesium as antithrombotic therapy Wiener Medizinische Wochenschrift 150(15-16): 343-347
Heyns, A.; Manga, P.; Jacobson, B.; Landless, P. 1998: Antithrombotic therapy for myocardial infarction--Part i South African Medical Journal 88(Suppl 2): C107-C114
Uchiyama, S. 2006: Antithrombotic therapy in acute ischemic stroke Rinsho Shinkeigaku 46(11): 844-846
Gotshall, R.A.; Harker, L.A. 1977: Using antithrombotic therapy in ischemic cerebrovascular disease Geriatrics 32(11): 101-104
Vojáček, J. 2014: Practical questions on therapy with new antithrombotic agents Vnitrni Lekarstvi 60(4): 389-395
Chazov, E.I.; Panchenko, E.P. 2000: Antithrombotic therapy in acute coronary syndrome Terapevticheskii Arkhiv 72(3): 65-75
Watson-Williams, E.J. 1986: Respiratory pharmacology. Antithrombotic and fibrinolytic therapy Clinics in Chest Medicine 7(3): 469-480
Markwardt, F. 1976: Biochemical and pharmacological principles of antithrombotic therapy Folia Haematologica 103(3): 293-312
Anitua, E.; Prado, R.; Orive, G. 2017: Platelet-Rich Plasma Therapy and Antithrombotic Drugs Pain Physician 20(2): E335-E336
Svetlikov, A.V.; Sapelkin, S.V.; Ishpulaeva, L.É; Gorbunov, G.N. 2018: Antithrombotic therapy in patients with peripheral artery diseases Angiologiia i Sosudistaia Khirurgiia 24(3): 13-17
Petralia, P.; Kakkar, A.K. 2004: Antithrombotic therapy with low molecular weight heparin in cancer patients European Journal of Medical Research 9(3): 119-124
Pfisterer, M.; Jockers, G.; Regenass, S.; Schmitt, H.E.; Grädel, E.; Burkart, F. 1989: How long should antithrombotic therapy be continued following aortocoronary bypass surgery? Schweizerische Medizinische Wochenschrift 119(43): 1518-1520
Pulanić, D. 2012: Venous thromboembolism, thrombophilia, and antithrombotic therapy in pregnancy in the light of the new guidelines Lijecnicki Vjesnik 134(7-8): 247-248
Fredd 1996: Adjunctive Antithrombotic Therapy with Stents, Current Status and Future Prospects Journal of Invasive Cardiology 8 Suppl E: 10e-11e
Nishida, M.; Matsuno, H.; Kozawa, O.; Ueshima, S.; Matsuo, O.; Collen, D.; Uematsu, T. 2000: tPA, but not uPA, significantly affects antithrombotic therapy by a glycoprotein IIb/IIIa antagonist, but not by a factor Xa inhibitor Journal of Cardiovascular Pharmacology 36(6): 770-775
Linchak, R.M.; Kompaniyets, O.G.; Nedbaykin, A.M.; Komkov, D.S.; Yusova, I.A. 2015: What Are the Realities of Prescription and Control of Antithrombotic Therapy in Atrial Fibrillation in Outpatient Practice? Kardiologiia 55(6): 34-39
Tsuzuki, N. 2002: Clinical characteristics and antithrombotic therapy for stroke prevention in patients with atrial fibrillation Hokkaido Journal of Medical Science 77(6): 563-570